Id |
Subject |
Object |
Predicate |
Lexical cue |
T375 |
0-177 |
Sentence |
denotes |
By studying a cohort of 18 COVID-19 patients and 64 healthy donors, Braun et al. (2020) found reactive CD4+ (83%) cells in blood-derived from the convalescing COVID-19 patients. |
T376 |
178-247 |
Sentence |
denotes |
These reactive T cells were found specifically against the S protein. |
T377 |
248-441 |
Sentence |
denotes |
Interestingly about 35% of SARS-CoV-2 seronegative healthy donors also showed the presence of S protein reactive CD4+ T cells indicating previous exposure to the related coronavirus infections. |
T378 |
442-596 |
Sentence |
denotes |
Simultaneously, another study has found SARS-CoV-2 specific CD4+ T (100%) and CD8+ T (70%) cells in convalescent patients (n = 20) (Grifoni et al., 2020). |
T379 |
597-802 |
Sentence |
denotes |
In addition to being majorly reactive against S protein, the study found additional targets of these T cells in the form of M, N, and ORF8 proteins and other non-structural proteins like NSP3, NSP4, ORF3a. |
T380 |
803-1030 |
Sentence |
denotes |
Further, in line with the study by Braun et al. (2020), T cells were found reactive against 40–60% of the SARS-CoV-2 uninfected patients, suggesting the presence of these reactive cells in response to previous viral infections. |